Zobrazeno 1 - 10
of 55
pro vyhledávání: '"MIRIAM ALVO"'
Autor:
Luis Toro, Luis Michea, Alfredo Parra-Lucares, Gabriel Mendez-Valdes, Eduardo Villa, Ignacio Bravo, Catalina Pumarino, Patricia Ayala, María Eugenia Sanhueza, Ruben Torres, Leticia Elgueta, Sebastian Chavez, Veronica Rojas, Miriam Alvo
Publikováno v:
Toxins, Vol 15, Iss 2, p 97 (2023)
End-stage renal disease (ESRD) patients are a population with high rates of COVID-19 and mortality. These patients present a low response to anti-SARS-CoV-2 immunization, which is associated with immune dysfunction. ESRD patients also present high pl
Externí odkaz:
https://doaj.org/article/9b123e1d94bf4a5ca4d6d25130396102
Autor:
Alondra Frías, Ignacio Gacitúa, Rubén Torres, Luis Toro, Erico Segovia, Miriam Alvo, Jorge Rodríguez, Carlos Romero, María Eugenia Sanhueza
Publikováno v:
Revista médica de Chile. 150:283-288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86f3b4c8ae366ab5037f4023d4e85245
https://doi.org/10.4067/s0034-98872022000300283
https://doi.org/10.4067/s0034-98872022000300283
Autor:
Felipe Simon, Pablo Tapia, Ricardo Armisen, Cesar Echeverria, Sebastian Gatica, Alejandro Vallejos, Alejandro Pacheco, Maria E. Sanhueza, Miriam Alvo, Erico Segovia, Rubén Torres
Publikováno v:
Frontiers in Physiology, Vol 8 (2017)
Chronic peritoneal dialysis (PD) therapy is equally efficient as hemodialysis while providing greater patient comfort and mobility. Therefore, PD is the treatment of choice for several types of renal patients. During PD, a high-glucose hyperosmotic (
Externí odkaz:
https://doaj.org/article/12ce798315f1485d8fa9b6cc7e2bdf9a
Autor:
Rubén Torres Díaz, Leticia Elgueta Segura, Alondra Frías Oyarzún, Miriam Alvo Abodovsky, Paula Segura Hidalgo, Luis Toro Cabrera
Publikováno v:
Revista médica de Chile v.149 n.1 2021
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: The discovery of the phospholipase A2 receptor antigen and its highly specific autoantibody (anti-PLA2R Ab) was useful for the diagnosis and follow-up of patients with membranous nephropathy (MN). Thus, some international guidelines recom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7236bfa4a9c532bbc1c6a96c9acc40e
https://doi.org/10.4067/s0034-98872021000100007
https://doi.org/10.4067/s0034-98872021000100007
Autor:
RODRIGO GONZÁLEZ, ARES TIRADO, LUIS A ROJAS, FRANCISCO J OSSANDÓN, MIRIAM ALVO, CARLOS WOLFF, DANIELA SEELENFREUND, PILAR DURRUTY, SERGIO LOBOS
Publikováno v:
Biological Research, Vol 42, Iss 2, Pp 189-198 (2009)
We present the analysis of an intronic polymorphism of the nephrin gene and its relationship to the development of diabetic nephropathy in a study of diabetes type 1 and type 2 patients. The frequency of the single nucleotide polymorphism rs#466452 i
Externí odkaz:
https://doaj.org/article/089f7307ee504c1fa84d7fc07188e568
Autor:
RODRIGO GONZÁLEZ, ARES TIRADO, MONSERRAT BALANDA, MIRIAM ALVO, INÉS BARQUÍN, PILAR DURRUTY, SERGIO LOBOS, DANIELA SEELENFREUND
Publikováno v:
Biological Research, Vol 40, Iss 3, Pp 357-364 (2007)
Diabetic nephropathy (DN) is one of the major complications of type 2 diabetes and is associated with coronary disease. Nephrin, a protein mainly expressed in glomeruli, is decreased in DN and other kidney diseases. Since insulin levels are misregula
Externí odkaz:
https://doaj.org/article/43deafa884a94ab5b50ea7887488d5bd
Autor:
Alondra, Frías, Ignacio, Gacitúa, Rubén, Torres, Luis, Toro, Erico, Segovia, Miriam, Alvo, Jorge, Rodríguez, Carlos, Romero, María Eugenia, Sanhueza
Publikováno v:
Revista medica de Chile. 150(3)
Anticoagulation in continuous renal replacement therapy (CRRT) is essential to counteract the coagulation cascade activation, induced by the dialysis circuit. Heparin is the most widely used anticoagulant, followed by regional citrate anticoagulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a3729c472bb3b0fae13ab3246c82fbf
https://pubmed.ncbi.nlm.nih.gov/36156711
https://pubmed.ncbi.nlm.nih.gov/36156711
Publikováno v:
Revista medica de Chile. 148(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5fdc4b83903a83fee93fc23d460d5c5
https://pubmed.ncbi.nlm.nih.gov/32730468
https://pubmed.ncbi.nlm.nih.gov/32730468
Autor:
Rubén Torres, María Eugenia Sanhueza, Sebastián Cabrera, Andres Boltansky, Erico Segovia, Miriam Alvo, Leticia Elgueta
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Diabetic nephropathy is one of the main causes of chronic kidney disease (CKD) in the world. In the past years new studies using SGLT-2 inhibitors in diabetic patients have shown benefit in both mortality and progression of CKD. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5542c59c4b73db5404db4a08cadb3e22
https://doi.org/10.1093/ndt/gfaa142.p1011a
https://doi.org/10.1093/ndt/gfaa142.p1011a
Autor:
Alondra, Frías Oyarzún, Paula, Segura Hidalgo, Luis, Toro Cabrera, Leticia, Elgueta Segura, Rubén, Torres Díaz, Miriam, Alvo Abodovsky
Publikováno v:
Revista medica de Chile. 149(1)
The discovery of the phospholipase A2 receptor antigen and its highly specific autoantibody (anti-PLA2R Ab) was useful for the diagnosis and follow-up of patients with membranous nephropathy (MN). Thus, some international guidelines recommend not per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d6e0844b1ce52eeda5e8cc273e6a2f5
https://pubmed.ncbi.nlm.nih.gov/34106130
https://pubmed.ncbi.nlm.nih.gov/34106130